CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 248 filers reported holding CANTEL MEDICAL CORP in Q4 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $15,853,000 | +79.5% | 201,031 | 0.0% | 0.51% | +39.9% |
Q3 2020 | $8,833,000 | -0.7% | 201,031 | 0.0% | 0.36% | -26.1% |
Q2 2020 | $8,892,000 | +23.1% | 201,031 | -0.1% | 0.49% | +7.9% |
Q1 2020 | $7,222,000 | -49.3% | 201,181 | +0.1% | 0.46% | -37.4% |
Q4 2019 | $14,253,000 | +25.4% | 201,031 | +32.3% | 0.73% | +9.0% |
Q3 2019 | $11,368,000 | -7.2% | 151,981 | 0.0% | 0.67% | -13.7% |
Q2 2019 | $12,256,000 | +20.3% | 151,981 | -0.2% | 0.77% | +12.7% |
Q1 2019 | $10,189,000 | +615.5% | 152,323 | +696.3% | 0.69% | +622.1% |
Q4 2018 | $1,424,000 | -19.3% | 19,129 | -0.2% | 0.10% | -22.1% |
Q3 2018 | $1,765,000 | -6.3% | 19,174 | +0.1% | 0.12% | -12.2% |
Q2 2018 | $1,884,000 | -11.9% | 19,157 | -0.2% | 0.14% | -15.2% |
Q1 2018 | $2,139,000 | -86.4% | 19,199 | -87.4% | 0.16% | -84.4% |
Q4 2017 | $15,679,000 | +9.2% | 152,414 | 0.0% | 1.05% | +3.5% |
Q3 2017 | $14,353,000 | +5595.6% | 152,414 | +4807.1% | 1.02% | +4738.1% |
Q2 2017 | $252,000 | -97.9% | 3,106 | -98.0% | 0.02% | -97.9% |
Q1 2017 | $12,174,000 | – | 151,981 | – | 1.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DIKER MANAGEMENT LLC | 1,383,325 | $136,064,000 | 48.67% |
Brown Capital Management | 3,345,000 | $329,014,000 | 3.38% |
Kimelman & Baird, LLC | 206,142 | $20,276,000 | 2.66% |
Conestoga Capital Advisors, LLC | 690,673 | $67,935,000 | 2.19% |
WASATCH ADVISORS LP | 1,772,992 | $174,391,000 | 2.10% |
Ranger Investment Management | 280,989 | $27,638,000 | 1.93% |
Freedom Day Solutions, LLC | 21,938 | $2,158,000 | 1.76% |
CAPITAL INSIGHT PARTNERS, LLC | 17,853 | $1,756,000 | 1.44% |
Geller Advisors LLC | 22,700 | $2,233,000 | 0.97% |
Sapphire Star Partners LP | 8,607 | $846,000 | 0.87% |